Zycov-d Vaccine

• 

  Zydus Cadila Begins Supply Of Covid Vaccine ZyCoV-D To Government

  Pharmaceutical company Zydus on Wednesday announced that it has started the supplies of its COVID-19 vaccine ZyCoV-D to the Government of India against their order from its newly commissioned state-of-the-art.

• 

  Central Drug Regulator Approves Shelf Life Of COVID-19 Vaccines CoviShield, Covaxin, ZyCoV-D

  The Central Drugs Standard Organisation (CDSO) has approved the shelf life of COVID-19 vaccines Covaxin to 12 months, Covishield to nine months, and ZyCoV-D to six months from the date of manufacture, the Lok Sabha was informed on Friday.

• 

  Zydus Cadila's Covid Vaccine ZyCoV-D To Be Used In 7 States Initially

  Zydus Cadila's Covid vaccine ZyCoV-D will initially be used in 7 states, including Maharashtra, Tamil Nadu, UP and Bengal, which have been recommended to identify the districts with a high number of people who have not received a single dose yet.

• 

  India To Buy 1 Crore Zydus Cadila 'Needle-Free' Covid Shots At Rs 265 Each

  The indigenously developed world's first DNA-based needle-free COVID-19 vaccine ZyCoV-D received emergency use authorisation from the drug regulator on August 20.

• 

  Zydus Cadila Agrees To Reduce Covid Vaccine Price To Rs 265 Per Dose: Report

  Zydus Cadila's ZyCov-D is the first vaccine cleared by India's drug regulator for inoculation of those aged 12 years and above

• 

  60 Lakh Doses Of Zydus Cadila's Vaccine Ready After Production In October: Report

  As many as 60 lakh doses of Zydus Cadila's three-dose COVID-19 vaccine ZyCoV-D are ready after production, said government sources.

• 

  Zydus Cadila's ZyCoV-D To Be Introduced In Covid Vaccine Drive Shortly: Centre

  The government today said Zydus Cadila's indigenously-developed needle-free Covid vaccine ZyCoV-D will be introduced in the nationwide vaccination drive very shortly and will be differentially priced than the jabs being used currently.

• 

  This Company Will Produce Pharma Firm Cadila's 3-Dose COVID-19 Vaccine 'ZyCov-D'

  Drugmaker Shilpa Medicare Limited said on Friday it had agreed to produce Cadila Healthcare Ltd's three-dose COVID-19 vaccine.

• 

  Decision On Zydus Cadila's Vaccine Prices Soon, Says NITI Aayog

  The discussion on the pricing of Zydus Cadila's COVID-19 vaccine ZyCoV-D is underway, said Dr VK Paul, Member (Health) NITI Aayog on Tuesday.

• 

  Cadila Healthcare Surges On Receiving Emergence Use Approval For COVID Vaccine

  ZyCoV-D is a needle-free vaccine administered using The PharmaJet a needle free applicator, which ensures painless intradermal vaccine delivery.

• 

  Stocks To Watch: Cadila Healthcare, Infosys, HDFC Bank

  Zydus Cadila's Covid vaccine, ZyCoV-D, has received approval for emergency use authorization from the Drug Controller General of India

• 

  Zydus Cadila Says "More Clarity" On Its Covid Vaccine Price By Next Week

  There will be more clarity on the prices of COVID-19 vaccine ZyCOV-D by next week, Zydus Group Managing Director Dr Sharvil Patel said today.

• 

  Zydus To Produce 1 Crore Doses Per Month By October, Says Chief

  Zydus Cadila, whose Covid vaccine ZyCoV-D for adults and children aged 12 years and above got approval yesterday, said it hopes to produce one crore doses per month by October.

• 

  "3 Doses, 66 Per Cent Efficacy": 5 Things To Know About Zydus Cadila's Covid Vaccine For Children

  Zydus Cadila's Covid vaccine ZyCoV-D, meant for adults and children aged 12 years and above, was today approved for "restricted use in emergency situation" by the Central Drugs Standard Control Organisation (CDSCO).

• 

  1st Covid Vaccine For Children Above 12 Approved In India

  India's drug regulator on Friday approved Zydus Cadila's three-dose COVID-19 DNA vaccine for emergency use in adults and children aged 12 years and above, bringing in the sixth vaccine authorised for use in the country.